Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)

2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-1271797/v1

Digital Resources/Online E-Resources

Inotropes Are Not Linked to Increased Mortality in Heart Failure

Digital Resources/Online E-Resources

Clinical characteristics and manifestations in older patients with COVID-19

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-28269/v4

Digital Resources/Online E-Resources

Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-38340/v2

Digital Resources/Online E-Resources

Effects of Beta Blockers and ACE Inhibitors after Left Ventricular Assist Device Implantation

Digital Resources/Online E-Resources

Inotropes Are Linked to Increased Mortality in Heart Failure

Digital Resources/Online E-Resources

Hemodynamic, Therapeutic, and Clinical Outcomes of Ambulatory Pressure-Guided Heart Failure Management

Digital Resources/Online E-Resources

What did we learn about VADs in 2016?

Digital Resources/Online E-Resources

Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair

DOI: 10.3390/ijms22031201

Digital Resources/Online E-Resources

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction

Copyright © 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

Digital Resources/Online E-Resources

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)

open access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. https://creativecommons.org/licenses/by-nc-nd/4.0

Digital Resources/Online E-Resources

What Did We Learn about VADs in 2017?

Digital Resources/Online E-Resources

Management of aortic insufficiency in patients with left ventricular assist device ̶ a retrospective analysis

Digital Resources/Online E-Resources

What Did We Learn about VADs in 2015?

Digital Resources/Online E-Resources

Left Ventricular Assist Device is a Viable Therapy in End Stage Hypertrophic Cardiomyopathy

Digital Resources/Online E-Resources

What Did We Learn About VADs in 2014?

Digital Resources/Online E-Resources

Age and Multimorbidities as Poor Prognostic Factors for COVID-19 in Hemodialysis: a Lebanese National Study

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-125343/v1

Digital Resources/Online E-Resources

What Did We Learn about VADs in 2018?

Digital Resources/Online E-Resources

Common clinical dilemmas in left ventricular assist device therapy: A glimpse into current trends

Digital Resources/Online E-Resources

A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema

The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Digital Resources/Online E-Resources